🐋 NKE $1.1M Turnaround Bet — Someone Just Aggressively Bought Long-Dated Nike Calls After Earnings Reset

📅 July 1, 2026 | ⚡ Lit Aggressive Buy Detected

✅ Updated 2026-07-02: next-day OPRA OI confirms the OPEN — see the RESOLVED box.

---

🎯 The Quick Take

Someone just dropped ≈$1.1M buying 4,848 Nike March 2027 $55 calls — confirmed aggressive, lifting the ask on a lit electronic venue with real demand consuming real offer-side liquidity. With NKE trading near ≈$42.88 just one day after a complicated FQ4 (headline beat, but powered by a one-time tariff refund with underlying demand still soft), this is a contrarian bet that the worst is already priced into one of the world's most iconic brands. The $55 call is ≈28% out-of-the-money and needs Nike to rally ≈34% to break even by March 2027 — cheap convex upside on the Elliott Hill turnaround thesis.

---

📊 Company Overview

NIKE, Inc. (NYSE: NKE) is the world's largest athletic footwear and apparel company, designing, developing and marketing Nike, Jordan, and Converse products across North America, EMEA, Greater China, and Asia Pacific/Latin America.

• Market Cap: ≈$61.2 billion (as of June 29, 2026)
• Industry: Consumer Discretionary — Textiles, Apparel & Luxury Goods
• Current Price: ≈$42.88 (July 1, 2026 at trade time), near the 52-week low of $40.00
• Primary Business: Footwear, apparel, equipment, and digital services across running, basketball, training, football, and lifestyle categories

Nike is mid-turnaround under CEO Elliott Hill, who launched the "Sport Offense" strategy to rebuild product innovation and restore wholesale relationships after an ill-fated overrotation to direct/digital. The stock sits ≈49% below its 52-week high of $80.16, reflecting deep investor skepticism about the pace and durability of the recovery. Running has now posted five consecutive quarters of double-digit growth — one genuine bright spot in an otherwise challenged picture.

---

💰 The Option Flow Breakdown

The Tape (July 1, 2026 @ 11:13 ET):

Flow tag: ⚡ LIT — this trade printed on the regular electronic market (displayed-book execution), purchased at the ask (100% across the bid-ask spread). The buyer consumed existing offer-side liquidity and did not negotiate — they paid full ask to get filled immediately.

---

✅ Open / Close — RESOLVED: July 2 Pre-Market OPRA OI Confirms an OPEN

The July 2 pre-market OPRA snapshot (reflecting July 1 EOD) is now in. Verdict: OPEN CONFIRMED.

OI rose by ≈9,001 ≈ the 10,000-contract print — a confirmed new opening long-call position (BTO).

---

🤓 What This Actually Means — Plain English

Here's the translation for regular folks: someone just paid $2.35 per contract (× 4,848 contracts × 100 shares = ≈$1.14M total) for the right to buy Nike stock at $55 anytime before March 19, 2027 — about 8.5 months from now.

The math on this bet:

• Strike price: $55.00
• Premium paid: $2.35 per share
• Breakeven at expiration: $55 + $2.35 = $57.35 (Nike needs to rally ≈34% from $42.88)
• How far OTM today: $55 strike vs $42.88 spot = ≈28% out-of-the-money
• Max loss: ≈$1.14M (if NKE is below $55 at March 2027 expiration — all premium evaporates)
• Max gain: Unlimited above $57.35 at expiration

Why would anyone buy a 34%-away-from-the-money call on a stock near 52-week lows? This is a turnaround option — the buyer is paying pennies on the dollar to bet that Nike's fundamental recovery materializes by early 2027. If the Elliott Hill strategy works and Nike re-rates toward analyst consensus ($54.13 average target per MarketBeat), these calls go from worth nothing to worth something substantial. The structure is deliberately cheap convex upside: limited downside (only the $1.14M premium), unlimited upside if the turnaround accelerates.

The execution is the real tell: this trade printed at the ask on a lit electronic venue. On a displayed-book market, printing at the ask means the buyer was a taker — they lifted the resting offer rather than posting a limit below the ask and waiting. They wanted in right now, at full offer. No patience, no working a mid-price, no negotiating. That is a confident, directional, bullish statement. Contrast this with a block cross (where a broker matches buyer and seller off-book at a negotiated price) — this is not that. This is a buyer who looked at NKE at $42.88 the day after a messy earnings report and said: "I want this position NOW."

What the tape PROVES (CONFIRMED): Lit electronic execution, 4,848 contracts at the ask, opening by size. The aggressive at-ask print is real demand.

What we INFER (NOT proven by tape alone): The buyer has a bullish directional view on NKE — a turnaround bet, not a hedge.

What the tape CANNOT tell us: Whether this is standalone or part of a larger portfolio. Who placed it. Whether they hold an offsetting position elsewhere. Identity of buyer or seller.

---

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

Nike has been a painful ride in 2026 — the stock started the year closer to $55–60 and has ground down ≈25–30%+ to current ≈$42–43 levels. It hit a 52-week low of $40.00 and is now trading near that floor. The June 30 post-earnings reaction told the whole story: initial pop on the headline beat, then reversal to close down ≈2% as investors looked past the tariff-refund margin optics and focused on the underlying demand weakness. We're sitting at a critical technical inflection — hold $40 and the turnaround thesis has room; break it and the picture gets significantly more challenging.

Gamma-Based Support & Resistance Analysis

Current Price: ≈$42.88

The gamma exposure map shows NKE boxed in between well-defined levels driven by heavy put interest below and call interest above:

🔵 Support Levels (Put Gamma Below Price):

• $42.50 — VERY STRONG (total GEX 15.4, nearest floor) — Just ≈0.55% below current price. This is the tightest nearby support — market makers are loaded with put exposure here and will mechanically buy any dip that approaches this level. Acts like a magnetic short-term floor.
• $40.00 — VERY STRONG (total GEX 11.6) — Aligns perfectly with the 52-week low. This is structural put protection territory — a major cluster of downside hedges. A sustained break here would mean NKE enters uncharted low territory with thin support below.

🟠 Resistance Levels (Call Gamma Above Price):

• $45.00 — STRONGEST resistance on the board (total GEX 22.9, largest single level) — Dealers hold enormous call exposure here and will mechanically sell into rallies. This is the ceiling NKE hasn't been able to crack. A clean close above $45 on volume would be a significant technical development.
• $47.50 — VERY STRONG (total GEX 10.8) — Second wall above $45. If $45 breaks, market makers have another line of defense here.
• $50.00 — VERY STRONG (total GEX 12.8) — Round-number cluster at a big round number. Would represent ≈+17% from current price. Getting through $50 would be a milestone moment for the turnaround.
• $55.00 — Moderate (total GEX 4.1) — This is exactly where today's call strike sits. Call gamma is building here (prior OI of 3,200 now being joined by today's ≈4,848 new contracts). If NKE rallies to $55, expect resistance to build further as dealer hedging increases.

Key insight: NKE is pinned between $42.50 support and $45.00 resistance. For the turnaround call to work, Nike needs to push through three consecutive gamma walls — $45, $47.50, and $50 — before the call strike even becomes relevant. Each wall requires sustained institutional demand to clear.

Implied Move Analysis

What options traders are pricing for upcoming expirations:

The single most important data point: The options market's implied upper range at the March 2027 Triple Witch (when this call expires) is $55.85 — almost exactly at the $55 call strike. Translation: the market is pricing ≈$55 as roughly the 1-sigma upper boundary of NKE's expected range by March 2027. The call buyer is betting on an outcome near or beyond that outer edge, paying $2.35 for a position that the market considers a tail scenario.

The lower range at March 2027 ($29.69) is the sobering flip side — options pricing reflects real downside risk too, especially given the China and digital headwinds. The range is wide and the uncertainty is genuine.

Near-term, the monthly OPEX (July 17) frames the ±7.7% / ±$3.29 range of $39.46–$46.04 — note that the lower bound nearly touches the 52-week low, and the upper bound is almost exactly the $45 gamma wall. The options market is pricing NKE as a stock boxed in that tight range for the next two weeks.

---

🎪 Catalysts

✅ Past Catalysts (Already Happened)

FQ4 2026 Earnings — June 30, 2026 (Yesterday)

Nike just reported fiscal Q4 2026 results with a headline beat that masked a complicated underlying picture — this is the context for today's call buy:

• 📊 Revenue: $11.0B vs $10.86B expected — beat the top line, but that's −1% reported / −4% currency-neutral. Not exactly blazing growth.
• 💰 Adjusted EPS: $0.20 vs $0.13 expected — significant beat on the bottom line.
• ⚠️ The catch: Gross margin jumped +890 bps to 49.2% — but ≈900 of those bps came from a one-time ≈$986M IEEPA tariff refund. Ex-tariff, underlying margins were roughly flat-to-down. This is accounting, not operations.
• 📉 Still soft: Greater China −17%, Nike Direct −9%, Digital −12% — the core demand problem is not resolved.
• ✅ Real bright spots: North America wholesale up double-digit full-year, inventory flat year-over-year (the excess-inventory hangover is finally cleaned up), running has delivered five consecutive quarters of double-digit growth.
• 📉 Market's verdict: Stock initially popped on the numbers, then reversed to close down ≈2%. The market discounted the tariff-driven margin and focused on the underlying softness.

The full-year FY2026 results: revenue $46.4B (flat reported, −2% currency-neutral), net income $3.11B. This is a company operating at the trough of a cycle — or so the bull case argues.

IEEPA Tariff Win (Supreme Court, February 2026)

The court ruling struck down the Trump tariffs. Nike expects ≈$986M in IEEPA tariff refunds, having already received ≈$300M in cash in FY2026. This was the primary driver of the Q4 margin beat. Note: Nike also faces a class-action lawsuit alleging "double recovery" — keeping the refunds while having raised consumer prices during the tariff period.

Two Rounds of Layoffs (FY2026)

≈775 U.S. distribution-center roles cut in January 2026 (automation), plus ≈1,400 global roles in April 2026. Structural cost reductions underway — but also a signal that revenue growth isn't bailing out the cost structure yet.

🔥 Upcoming Catalysts (What's Ahead)

• 📅 New CFO David Denton — starts August 17, 2026. Denton brings CFO experience from Pfizer, Lowe's, and CVS Health. A fresh financial voice mid-turnaround — watch for any guidance-framing changes and capital allocation signals. Prior CFO Matthew Friend departs September 4 after an orderly transition.

• 📅 Fiscal Q1 FY2027 Earnings — expected late September 2026. Guidance is already set: EPS "flattish" through the first two quarters of FY2027, with Q1 gross margin expected slightly positive year-over-year. The critical metric to watch: whether Greater China revenue decline is moderating from the −17%/−20% trajectory, and whether North America wholesale momentum holds.

• 📅 Investor Day — November 16–17, 2026. Two-day event expected to lay out medium-term financial targets under Hill. This is potentially the most significant near-term re-rating catalyst. If Nike provides credible multi-year margin and revenue frameworks, the stock could move toward analyst consensus ($54.13). This event falls within the March 2027 call's life — the call buyer may be explicitly targeting this as the inflection point.

• 📅 "Sport Offense" Product Wave — H2 FY2027 / Spring 2027. Hill's first comprehensive product rollout across all sports launches spring 2027 — more than a dozen new footwear styles. This is what the turnaround ultimately depends on: new products that recapture share from On, Hoka, and Adidas. The Aero-FIT technology extends into running apparel by fall 2026 as a preview.

• 📅 Greater China Premium Reset (Holiday 2027). Locally-designed product targeting the Chinese consumer doesn't arrive until holiday 2027 — this is a multi-quarter rebuild, not a quick fix. The call expires before this fully plays out.

---

🎲 Price Targets & Probabilities

Using gamma levels, implied move data, and the catalyst timeline through March 2027:

📈 Bull Case (≈20% probability)

Target: $55–$60 by March 2027 (+28–40% from here)

How we get there:

• 💪 Investor Day (November 16–17) delivers credible medium-term targets — stock re-rates toward analyst average price target of $54.13
• 📦 Inventory clean + North America wholesale momentum continues → multiple quarters of sequential improvement
• 🇨🇳 Greater China decline moderates from −17% to −5% or better by Q1/Q2 FY2027 (not expecting a positive turn, just a slowdown in the freefall)
• 📅 New CFO David Denton signals improved capital allocation — buybacks accelerate, attracting value investors
• 🏃 Running + early "Sport Offense" product previews generate buzz before March 2027 expiration
• 🧱 NKE breaks the $45 gamma wall, which triggers technical momentum toward $50, then the $55 resistance zone

At $57.35, the Mar 2027 $55 call breaks even. Above $57.35, it's profitable. Note: the options market already prices $55.85 as the 1-sigma upper range at March 2027 expiration — a demanding but not impossible outcome.

Why only 20%: Getting from $43 to $55+ in 8.5 months requires multiple catalysts to land sequentially AND China/digital weakness to materially slow. Analysts are at Hold, not Buy — consensus target $54.13 is above the call strike. A lot needs to go right.

🎯 Base Case (≈55% probability)

Target: $40–$50 range (consolidation)

Most likely scenario:

• ✅ Q1 FY2027 earnings (late September) come in "flattish" as guided — no disaster, no fireworks
• 🔄 NKE oscillates between $40 support and $45–$47.50 resistance throughout the rest of 2026
• 📉 China declines slow but don't reverse — the premium repositioning is holiday-2027 dated, not 2026
• 📅 Investor Day November delivers a credible long-term plan but doesn't immediately re-rate to $54+ consensus
• 💤 The Mar 2027 $55 call expires worthless or with minimal value — the $1.1M was the cost of a lottery ticket that didn't hit

The call buyer loses most or all of the $2.35 premium. The turnaround is real but slower than a 34% rally in 8.5 months.

📉 Bear Case (≈25% probability)

Target: Below $40 — 52-week low break

What could go wrong:

• 😰 Greater China deterioration accelerates beyond −20% guided run-rate — domestic brands (Anta, Li-Ning) intensify share gains
• 📉 Q1 FY2027 print (late September) misses even the already-low bar, triggering another round of estimate cuts
• 💸 Macro/consumer spending headwinds bite discretionary apparel harder than expected — NKE is not a recession stock
• ⚖️ Tariff class-action generates unexpected headlines or adverse rulings
• 📊 A break below $40 (52-week low) triggers technical selling toward the $35–36 lower range

In the bear case, the call expires worthless — max loss of ≈$1.14M for the buyer.

---

💡 Trading Ideas

🛡️ Conservative — Entry-Level Investor ("I want exposure but not lottery-ticket risk")

Play: Consider the stock itself, not options.

If you believe in the turnaround story, buying NKE shares at $42–43 near 52-week lows gives you real exposure without the all-or-nothing binary of OTM calls. The $40 gamma support + 52-week low provides a clear risk reference — you can set a mental stop around $39–39.50, and you have defined downside with a natural floor.

Why this beats copying the call for beginners: You don't need NKE to rally 34% to make money. A recovery to $50 = +16% return on stock vs. calls that expire worthless if NKE doesn't clear $55. If the November Investor Day goes well and NKE trades to $48–50, you make a solid gain without ever needing the turnaround to be "complete."

Position sizing: Keep NKE to 2–3% of portfolio max given the fundamental uncertainty. This is a turnaround bet, not a blue-chip compounder right now.

Risk level: Moderate (stock drawdown possible if $40 breaks). Skill level: Beginner-friendly.

⚖️ Balanced — Swing Trader ("I want leverage but a more realistic breakeven")

Play: Buy Jan 2027 $47 or $50 calls instead of copying the $55 strike.

Rather than replicating the whale's exact $55 call (needs 34% rally to break even), a Jan 2027 $47 or $50 call has a breakeven around $49–53 — in line with analyst consensus and more achievable if the November Investor Day surprises to the upside. Less cheap on an absolute basis, but far higher probability of success.

Entry timing: Watch the $45 gamma wall. If NKE closes above $45 on volume (a genuine breakout through the strongest resistance level), that is the technical signal to enter. Don't chase into resistance — wait for confirmation.

Why this works: The $45 breakout would signal the turnaround is gaining traction in real time, and entering on that signal gives you both technical AND fundamental momentum rather than trying to pick the bottom cold.

Risk level: Moderate (can lose 100% of premium). Skill level: Intermediate.

🚀 Aggressive — YOLO Trader ("I want to replicate the whale trade at my scale")

Play: Copy the trade — Mar 2027 $55 calls at ≈$2.35.

For a smaller-scale version: 10 contracts = $2,350 total risk, potential 3–10x return if Nike hits $60–65 by March 2027.

The P&L math on 10 contracts:

• Cost: $2.35 × 1,000 = $2,350 max loss (defined, total)
• NKE at $60 at March expiration: intrinsic $5, profit = $2.65 × 1,000 = $2,650 (+113%)
• NKE at $65 at March expiration: intrinsic $10, profit = $7.65 × 1,000 = $7,650 (+326%)
• NKE below $55 at expiration: −$2,350 (−100%)

CRITICAL WARNINGS — Read these before entering:

• ❗ This call is ≈28% OTM. The options market prices $55.85 as the 1-sigma upper range at March 2027 — you're betting near or beyond that outer boundary.
• ❗ Time decay will bleed this position every day NKE sits below $50. OTM calls with 8 months of life feel "safe on time" but theta compounds quietly.
• ❗ Statistically, the majority of OTM long calls expire worthless. This is a lottery ticket with a defined ticket price. Plan mentally to lose the full $2.35.
• ❗ Only risk money you can afford to lose completely — this is speculation, not investing.

Risk level: HIGH (total loss of premium is the expected outcome more often than not). Skill level: Advanced only.

💡 Premium Collector — Income Trader ("I'd rather sell into this excitement")

Play: Sell covered calls at the $45 resistance level if you already own NKE shares.

With NKE near $43 and the $45 strike serving as the strongest gamma resistance on the board (total GEX 22.9), selling near-term covered calls at $45 (August or September expiration) collects income while the stock consolidates. The gamma structure means market makers are mechanically selling into that level too — you're on the same side as the structural flow.

• If NKE stays below $45: keep 100% of the premium collected. Repeat the process the following month.
• If NKE breaks above $45 (bullish signal!): your shares get called away at $45 — a meaningful gain from $42–43 — and you can reassess whether to re-enter.

The risk: If the November Investor Day triggers a sharp rally past $45, you cap your upside at $45 (plus the premium collected). That is the trade-off inherent in covered call writing.

Requirements: You need to own at least 100 shares of NKE per contract. Skill level: Intermediate (requires existing stock position).

---

⚠️ Risk Factors

Be honest with yourself about what could go wrong here:

• 📉 China is genuinely in freefall and the fix is years away. Greater China revenue was −17% in Q4 with a guided ≈−20% run-rate ahead. Locally-designed product and premium repositioning don't arrive until holiday 2027. Domestic competitors (Anta, Li-Ning) are gaining permanent structural share. If China doesn't stabilize, it drags on every earnings print through this call's life.

• 💸 The Q4 beat was a one-time accounting event, not operational progress. The ≈$986M tariff refund injected ≈900 bps of gross margin that won't repeat. Underlying digital demand was −12%, Nike Direct −9%. The core consumer is not returning to Nike at full price yet.

• ⏰ The product refresh doesn't launch until spring 2027 — right at this call's expiration. The "Sport Offense" full rollout launches spring 2027. If the product doesn't excite the market immediately, the timing is extremely tight for the call to capture any rerating benefit.

• 🏃 Competition is structural, not cyclical. On and Hoka continue taking high-margin performance running share while Adidas owns lifestyle. Nike isn't fighting a temporary trend — it ceded positioning over several years and rebuilding takes multiple product cycles.

• 🏛️ Class-action and leadership transition add headline risk. Nike faces a consumer class-action alleging double recovery on the tariff refunds. Meanwhile, new CFO David Denton starts August 17 — CFO transitions mid-turnaround always create short-term uncertainty around capital allocation and guidance.

• 🎯 Breakeven ($57.35) is above analyst consensus ($54.13). J.P. Morgan cut its target to $47, Stifel is at $50 — the "Moderate Buy" consensus has an average target of $54.13. The call's breakeven of $57.35 requires NKE to exceed what most professional analysts think is fair value within 8.5 months. The call buyer needs the analysts to be wrong, and wrong fast.

• 📊 Three gamma walls stand between here and the call strike. Getting from $43 to $55 requires punching through $45 (strongest resistance at 22.9 GEX), then $47.50, then $50 — three consecutive gamma walls, each requiring sustained institutional buying to clear. These walls don't disappear on their own.

• 💡 Most OTM calls expire worthless. This is the base case statistically for any 28%-OTM call with 8.5 months to expiration. The $2.35 premium reflects a low probability outcome. The call buyer knows this — they're paying for the asymmetric upside, not expecting a high probability of profit.

---

🎯 The Bottom Line

Here's the deal: A well-capitalized trader just paid ≈$1.1M to bet that Nike's turnaround reaches escape velocity by March 2027 — and they did it aggressively, lifting the offer on a lit electronic venue to signal they wanted in immediately. That's not random noise. That's conviction.

The thesis is straightforward: Nike is the world's most recognizable athletic brand, trading at ≈$61B market cap near multi-year lows after a brutal peak-to-trough decline. The inventory is finally clean, North America wholesale is actually inflecting, and three catalysts sit within this call's 8.5-month life — a new CFO on August 17, the FQ1 FY2027 print in late September, and the November 16–17 Investor Day that could be the genuine re-rating event the market has been waiting for.

The $55 call for $2.35 is the options version of that thesis: "I don't need this to work immediately. I just need Nike to get its act together by March 2027."

What this trade tells us:

• 🎯 The buyer has real conviction — $1.1M on an OTM call that needs a 34% rally is not a casual hedge
• 📅 The November Investor Day is likely the catalyst they're counting on as the primary inflection point
• 💡 At $2.35 per contract, the risk is defined and cheap relative to the potential upside — classic asymmetric structure
• ⚠️ The breakeven ($57.35) exceeds Wall Street's consensus — this needs analysts to be too pessimistic for the call to profit

If you own NKE: This aggressive call buy adds a modest positive sentiment signal, but don't mistake one trade for a fundamental change. Keep watching the $45 gamma wall as the key near-term technical threshold. A sustained close above $45 would be a genuine development worth paying attention to.

If you're considering entering: The $40 support (52-week low and strong gamma floor) is your line in the sand. As long as Nike holds $40, the turnaround thesis has room to develop. Break below $40 with volume, and the picture changes materially.

Mark your calendar — key dates:

• ✅ July 2 — OPRA OI confirmed the OPEN (resolved)
• 📅 August 17, 2026 — New CFO David Denton starts; first financial guidance commentary
• 📅 Late September 2026 — FQ1 FY2027 earnings (first real test of the "flattish" guidance)
• 📅 November 16–17, 2026 — Nike Investor Day (potential re-rating catalyst; this call lives or dies here)
• 📅 Spring 2027 — First full "Sport Offense" product wave launches
• 📅 March 19, 2027 — Expiration of this $55 call (≈261 days from today)

Final verdict: Interesting, conviction-sized, aggressive turnaround bet on a brand with real structural advantages and a real turnaround plan — but the math is demanding. The $55 call only wins if multiple things go right in sequence: China stabilizes, Investor Day impresses, product execution lands, and NKE clears three gamma walls along the way. As a signal of market psychology, it says at least one well-capitalized player thinks Nike at $43 near multi-year lows is a mispriced recovery story. Whether they're right is the $1.1M question.

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational and informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance of similar trades or strategies does not guarantee future results. The call option analyzed here is approximately 28% out-of-the-money; the majority of such far-OTM options expire worthless, and buyers should be prepared to lose the entire premium paid. The trade discussed represents a single data point and does not imply you should replicate it. All catalyst links and source materials are cited from publicly available research. Always conduct your own independent research and consider consulting a licensed financial advisor before making any investment decision. Options involve unique risks including time decay, volatility changes, and the potential for total loss of invested capital.

---

About NIKE, Inc.: NIKE, Inc. is the world's largest athletic footwear and apparel company, designing, marketing and selling Nike, Jordan, and Converse branded products globally, with a market cap of ≈$61.2 billion in the Consumer Discretionary / Textiles, Apparel & Luxury Goods sector.

Last updated: 2026-07-02 — open/close resolved via next-day OPRA OI (reflecting July 1 EOD).